Liver cirrhosis stem cell therapy(SCM Lifescience)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLiver cirrhosis stem cell therapy(SCM Lifescience)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScm Lifescience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesScm Lifescience Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A